🔗 Share this article

An underground economy for unlicensed slimming drugs is being driven by social media fitness personalities and sellers on communication apps, according to new investigations.

Experimental Drug Gaining Popularity Online

The experimental drug, which is still in research studies, is being promoted by online personalities for its supposed fat-burning properties. Followers are urged to message these accounts directly for supplier links, while also receiving promotional offers.

Thriving Commerce on Messaging Platforms

Separately, a robust market exists on messaging services, where communities with numerous of participants share comparison photos, injection guides and assertions of rapid British shipping. Sellers promote the drug there before directing buyers to WhatsApp for transactions.

Learning About Retatrutide

Retatrutide is an experimental injectable created by US drugmaker Eli Lilly. The drug targets three gut hormones – GLP-1, glucose-dependent insulinotropic polypeptide and pancreatic hormone. Early trials indicate it could help patients lose up to 25% of their body weight. Nicknamed the “triple G”, the substance is being hailed digitally as the successor to Ozempic.

Healthcare Professionals Voice Worries

However, doctors and pharmacists have warned that the distribution of what is still an unlicensed drug in the UK is a cause for concern and could result in individuals injecting products of uncertain source.

Some experts said the demand for the experimental drug could be connected to the increasing price of approved slimming treatments such as Mounjaro.

Legal Position and Implementation

Marketing retatrutide on TikTok or messaging apps is prohibited in the UK, as it is an unlicensed drug that must not be promoted or distributed for human use under the British medical regulations.

Some influencers try to circumvent the rules by referring to the substance as a “research chemical” or citing it as “not for human consumption”. The substance is not a restricted drug, but advertising and distribution can still breach pharmaceutical, marketing, and consumer laws, potentially leading to penalties, prosecution or prison.

Service Response and Material Removal

Based on the social media company, the service has taken down violative material and prohibited related keywords and query recommendations. The company said it was dedicated to keeping the service safe and allocating resources in enhancing enforcement strategies.

Digital Trading Activities

Research also discovered communities with up to nine thousand participants marketing retatrutide using Telegram's built-in discovery tool, which functions like a online catalog. Typing “retatrutide” immediately displays channels with numerous of users, filled with images of weight loss, positive reviews and detailed instructions for preparing or injecting at home.

After moments of joining one group, a vendor shared WhatsApp details, where most transactions occur. The seller provided an instruction manual and promised shipping within two days. When asked whether the substance was authentic, one seller responded: “You can’t be sure.” Another provided a image of a supposed laboratory certificate. Not one asked about weight, health issues or past usage.

Product Information and Costs

Within these communities, posts display black plastic packages with postal service labels, stating to contain new batches. One message stated: “It took eight of us to load them this morning.”

Buyers can choose between dry substance containers, prepared at residence with sterile water, or ready-to-use injectors typically priced at £160 for 20mg. When questioned how much time a pen should last, vendors give conflicting responses ranging from a few weeks to “depends on your body”.

Service Oversight and Safety Measures

A representative for the messaging service said it regularly monitored harmful content on its service including content that encouraged the “misuse of controlled medications”. The organization noted that it eliminated “millions of pieces of harmful content each day”.

Medical Professional Warnings

“People are injecting substances they cannot confirm. Even if the research behind retatrutide is sound, these online products may not include what they claim,” stated Jason Murphy, the head of pharmacy at Chemist4U.

Dr Crystal Wyllie of Asda Online Doctor linked the increase in demand to recent cost increases for authorized weight-loss medications such as Mounjaro. “With prices rising, patients are using online platforms. But counterfeit treatments are highly dangerous. You can’t be certain what’s inside or whether the environment they were produced in was clean,” she explained.

Her staff has previously encountered patients injured by self-injection from unconfirmed sources. “We understand the frustration, but buying from Telegram or WhatsApp is gambling with your health,” stated Wyllie. “These materials could be impure or improperly measured.”

Producer Position

A representative from the pharmaceutical company said retatrutide was in third stage clinical trials and had not been reviewed or authorized by any government authority globally. “Consequently at this time no one can market [it] for human use,” they explained, adding that any item “misleadingly claiming itself as a company investigational substance not yet approved … may subject users to possibly serious medical dangers”.